CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors

Although the postoperative recurrence rate for pancreatic neuroendocrine tumors (PNETs) is reported to be 13.5%‐30%, the paucity of valuable biomarkers to predict recurrence poses a problem for the early detection of relapse. Hence, this study aimed to identify new biomarkers to predict the recurren...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Med
Huvudupphovsmän: Miki, Masami, Oono, Takamasa, Fujimori, Nao, Takaoka, Takehiro, Kawabe, Ken, Miyasaka, Yoshihiro, Ohtsuka, Takao, Saito, Daisuke, Nakamura, Masafumi, Ohkawa, Yasuyuki, Oda, Yoshinao, Suyama, Mikita, Ito, Tetsuhide, Ogawa, Yoshihiro
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2019
Ämnen:
Clinical Cancer Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6639196/
https://ncbi.nlm.nih.gov/pubmed/31129920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2232
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk